Foster & Motley’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Buy |
19,969
+1,030
| +5% | +$125K | 0.14% | 147 |
|
|
2025
Q1 | $2.11M | Buy |
18,939
+222
| +1% | +$24.7K | 0.13% | 152 |
|
|
2024
Q4 | $1.82M | Sell |
18,717
-221
| -1% | -$21.5K | 0.12% | 163 |
|
|
2024
Q3 | $2.18M | Buy |
18,938
+2,800
| +17% | +$322K | 0.14% | 144 |
|
|
2024
Q2 | $1.72M | Buy |
16,138
+3,580
| +29% | +$381K | 0.12% | 159 |
|
|
2024
Q1 | $1.22M | Buy |
12,558
+3,110
| +33% | +$301K | 0.08% | 192 |
|
|
2023
Q4 | $954K | Buy |
9,448
+4,358
| +86% | +$440K | 0.07% | 201 |
|
|
2023
Q3 | $518K | Buy |
5,090
+1,467
| +40% | +$149K | 0.04% | 263 |
|
|
2023
Q2 | $366K | Hold |
3,623
| – | – | 0.03% | 313 |
|
|
2023
Q1 | $333K | Sell |
3,623
-52
| -1% | -$4.78K | 0.03% | 320 |
|
|
2022
Q4 | $333K | Buy |
3,675
+450
| +14% | +$40.8K | 0.03% | 316 |
|
|
2022
Q3 | $245K | Sell |
3,225
-180
| -5% | -$13.7K | 0.02% | 325 |
|
|
2022
Q2 | $288K | Hold |
3,405
| – | – | 0.03% | 311 |
|
|
2022
Q1 | $299K | Sell |
3,405
-799
| -19% | -$70.2K | 0.02% | 304 |
|
|
2021
Q4 | $368K | Sell |
4,204
-2,650
| -39% | -$232K | 0.03% | 278 |
|
|
2021
Q3 | $561K | Buy |
6,854
+813
| +13% | +$66.5K | 0.05% | 229 |
|
|
2021
Q2 | $551K | Sell |
6,041
-318
| -5% | -$29K | 0.05% | 224 |
|
|
2021
Q1 | $544K | Buy |
+6,359
| New | +$544K | 0.05% | 214 |
|
|
2015
Q2 | – | Sell |
-2,472
| Closed | -$218K | – | 183 |
|
|
2015
Q1 | $218K | Hold |
2,472
| – | – | 0.05% | 171 |
|
|
2014
Q4 | $205K | Buy |
2,472
+95
| +4% | +$7.88K | 0.05% | 167 |
|
|
2014
Q3 | $200K | Sell |
2,377
-89
| -4% | -$7.49K | 0.05% | 162 |
|
|
2014
Q2 | $200K | Buy |
+2,466
| New | +$200K | 0.05% | 159 |
|